Aoxing Pharmaceutical (AXN) Reports Q1 EPS of $0.02

Aoxing Pharmaceutical (NYSE: AXN) reported Q1 EPS of $0.02, versus $0.00 reported last year. Revenue for the quarter came in at $8.75 million, versus $4.57 million reported last year.

For earnings history and earnings-related data on Aoxing Pharmaceutical (AXN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c